- Home
- BYSI vs SRTS Comparison
BYSI vs SRTS Comparison
Compare BYSI & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BYSI | SRTS |
|---|---|---|
| Founded | 2010 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.4M | 75.9M |
| IPO Year | 2016 | 2016 |
Fundamental Metrics
Financial Performance| Metric | BYSI | SRTS |
|---|---|---|
| Price | $1.83 | $3.92 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.67 |
| AVG Volume (30 Days) | 19.6K | ★ 75.4K |
| Earning Date | 01-01-0001 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $3.81 |
| Revenue Next Year | N/A | $38.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.98 | $3.03 |
| 52 Week High | $3.44 | $5.92 |
Technical Indicators
Market Signals| Indicator | BYSI | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 70.18 | 37.56 |
| Support Level | $1.70 | $3.63 |
| Resistance Level | $1.83 | $4.86 |
| Average True Range (ATR) | 0.13 | 0.26 |
| MACD | 0.05 | -0.03 |
| Stochastic Oscillator | 93.75 | 1.09 |
Price Performance
Historical ComparisonAbout BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.